Webinar: RCNi 2021
The pivotal role nurses have in the quality of life of GEP-NET patients
Click the video below and watch the highly informative RCNi webinar on the pivotal role nurses have in the quality of life of patients with gastroenteropancreatic neuroendocrine tumours. Chaired by Irene Wotherspoon, the expert speakers Nikie Jervis and Mike Tadman discuss the patient’s journey to diagnosis, referral and treatment; the role of the neuroendocrine tumour (NET) nurse; and the management of patients treated with peptide receptor radionuclide therapy (PRRT). The faculty provided further insights on audience-submitted questions during the live Q&A.
If you don't have time to watch the whole video, click on the bookmark button to select a section that interests you.
This Advanced Accelerator Applications-sponsored webinar was part of the Royal College of Nursing RCNi virtual meeting.
Irene Wotherspoon (Chair)
Advanced Clinical Nurse Specialist, The Beatson West of Scotland Cancer Centre
Irene Wotherspoon qualified in 1991 and initially worked in a variety of medical wards. Following completion of a BSc (Health Studies), Irene moved to Ross Hall Hospital in 1999 to lead and develop the Oncology and Breast Cancer Nurse Service.
In 2003, Irene moved into the first substantive post as Palliative Care Clinical Nurse Specialist in the Victoria Infirmary, Glasgow. In the subsequent years, Irene has had a combination of clinical and education roles within palliative and cancer care and universities.
Irene completed an MSc in Specialist Nursing (Palliative Care) and gained a Specialist Practitioner Qualification in Palliative Care in 2009. In recognition of her academic work, Irene has been recognised as Fellow of the Higher Education Academy.
In May 2016, Irene took up post as Advanced Clinical Nurse Specialist for Neuro-endocrine Neoplasms and Thyroid Cancer at the Beatson West of Scotland Cancer Centre. She has subsequently completed a Clinical Skills module and become a non-medical prescriber. She is involved in teaching and education in addition to her clinical work.
The Beatson West of Scotland Cancer Centre was accredited as a European Centre of Excellence in the treatment of neuroendocrine neoplasms in 2019.
Senior Patient Support and Information Nurse Specialist, Neuroendocrine Cancer UK
Nikie Jervis is a Senior Patient Support & Information Nurse Specialist and Education Lead at Neuroendocrine Cancer UK. In this role, she utilises key face-to-face, telephone and online nurse specialism skills to support neuroendocrine cancer patients and their families and is also involved in information and education resource development and delivery. Prior joining NCUK, Nikie was the Lead HPB/Neuroendocrine Cancer Clinical Nurse Specialist at King's College Hospital from 1999 to 2015 and a core team member of the European Neuroendocrine Tumour Society’s accredited NET Centre MDT.
Senior Clinical Nurse Specialist in Neuroendocrine Tumours, Churchill Hospital, Oxford
Mike Tadman has 30 years’ experience in cancer practice and education, mainly within Oxford. He set up the Neuroendocrine Tumours (NET) Specialist Nursing Service at the Oxford University Hospitals NHS Foundation Trust in 2013. Mike works closely with Neuroendocrine Cancer UK and has completed a survey of how centres commence and dose somatostatin analogues (SSAs) for patients with NETs, which he has presented internationally. He has also led practice development initiatives in Oxford, leading to streamlined pathways for patients with NETs, and published results of an audit on test-dosing for SSAs.
Currently, Mike is Senior Clinical Nurse Specialist in Neuroendocrine Tumours at Churchill Hospital in Oxford. He is also co-editor of the Oxford University Press Cancer Nursing Handbook, having just completed its second edition, and was lead author on two recent chapters on NETs and multiple endocrine neoplasia (MEN) in ‘Advanced Practice in Endocrinology Nursing’.